Consistent with the results obtained upon analyzing TCGA datasets, CRC patients classified as NPC1L1 high had significantly poorer survival than those classified as NPC1L1 low (P = 0.036 and 0.049) (Fig. 3b and c). This evidence concerns the gene NPC1L1 and colorectal carcinoma.